Get the latest tech news
AstraZeneca Signs Up For $555 Million AI Deal With Algen To Develop Therapies
AstraZeneca has licensed Algen Biotechnologies' AI-powered gene-editing platform, AlgenBrain, to develop immune-related therapies in a deal worth up to $555 million. Reuters reports: AstraZeneca will get exclusive rights to develop and sell approved therapies, if any, that target immune system-rela...
None
Or read this on Slashdot